A detailed history of Cwm, LLC transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Cwm, LLC holds 661 shares of INMB stock, worth $1,242. This represents 0.0% of its overall portfolio holdings.

Number of Shares
661
Previous 453 45.92%
Holding current value
$1,242
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 15, 2025

BUY
$1.76 - $2.91 $366 - $605
208 Added 45.92%
661 $1,000
Q2 2025

Jul 25, 2025

SELL
$2.31 - $8.26 $242 - $867
-105 Reduced 18.82%
453 $1,000
Q1 2025

May 01, 2025

BUY
$4.93 - $10.48 $1,360 - $2,892
276 Added 97.87%
558 $4,000
Q4 2024

Feb 04, 2025

BUY
$4.4 - $6.43 $1,144 - $1,671
260 Added 1181.82%
282 $1,000
Q3 2024

Oct 08, 2024

BUY
$4.86 - $9.86 $106 - $216
22 New
22 $0

Others Institutions Holding INMB

About Inmune Bio, Inc.


  • Ticker INMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,946,000
  • Market Cap $33.7M
  • Description
  • INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...
More about INMB
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.